Summary Minisatellite DNA probes which can detect a large number of autosomal loci dispersed throughout the human genome were used to examine the constitutional and tumour DNA of 35 patients with a variety of cancers of which eight were of gastrointestinal origin. Somatic changes were seen in the tumour DNA in ten of the 35 cases. The changes included alterations in the relative intensities of hybridising DNA fragments, and, in three cases of cancers of gastrointestinal origin, the appearance of novel minisatellite fragments not seen in the corresponding constitutional DNA. The results of this preliminary study suggests that DNA fingerprint analysis provides a useful technique for identifying somatic changes in cancers.
It is now widely accepted that tumours arise through the accumulation of several genetic changes affecting the control of cell proliferation (Klein & Klein, 1985) . Over 30 different cellular loci presumably involved in these pathways have now been identified (Barbacid, 1986) . These genes have been designated oncogenes whereas their counterparts in normal cells are referred to as proto-oncogenes. Activation of the cellular oncogenes is thought to be an important step in the development of neoplasia, and the somatic change which causes this activation can be a gross chromosomal translocation or just a single point mutation (Barbacid, 1986) . Somatic changes which result from major chromosomal rearrangements are detectable by karyotype analysis (Sandberg, 1980; Yunis, 1983) although chromosomal preparations from solid tumours can be technically difficult. DNA analysis can also detect somatic variations; in particular, chromosomal loss or the development of somatic homozygosity can now be demonstrated by restriction fragment length polymorphism (RFLP) analysis using single copy gene probes (Wainscoat & Thein, 1985) . This approach is ideal for the study of tumours such as retinoblastoma (Cavenee et al., 1983) or Wilms' tumour (Koufos et al., 1984; Orkin et al., 1984; Reeve et al., 1984) in which there is a consistent loss of a particular chromosomal region. For other tumours a battery of DNA probes representing different loci may be used to detect chromosomal loss (Dracopoli et al., 1985) .
We describe here an alternative approach for screening the human genome for somatic changes in cancers using DNA fingerprint analysis. DNA fingerprints represent multiple hypervariable fragments derived from a large number of autosomal loci dispersed throughout the human genome and show both somatic and germline stability (Jeffreys et al., 1985a (Jeffreys et al., , b, 1986 . We have analysed the constitutional and tumour DNA of 35 cancer patients and observed somatic changes in the tumour DNA in ten cases. The changes include alterations in the relative intensities of hybridising DNA fragments, and, in three cases of cancers of gastrointestinal origin, the generation of novel minisatellite fragments not seen in the corresponding constitutional DNA.
Materials and methods

Patients
Thirty-five patients with a variety of cancers were studied (Table I) histological examination and the cases of myelodysplasia (MDS), all of which had karyotypic abnormalities, fulfilled the FAB classification (Bennett et al., 1982) . All tissues and peripheral blood leucocytes were obtained before chemotherapy or radiotherapy. DNA was isolated from tumour tissues (representing tumour DNA), from peripheral blood leucocytes (representing constitutional DNA) and, in some cases, from adjacent normal tissue. In the MDS patients, tumour DNA was obtained from bone marrow or peripheral blood leucocytes and constitutional DNA from Epstein-Barr virus (EBV)-transformed B-cells.
DNA Analysis DNA was isolated from peripheral blood leucocytes by proteinase-K and phenol-chloroform extraction as described (Old & Higgs, 1983) . The fresh solid tissues were dissected free of fat, minced and digested overnight at 37°C in 0.5% SDS and proteinase-K; DNA was subsequently isolated by phenol-chloroform extraction as for the leucocytes. Equivalent amounts of constitutional or tumour DNA (8-10 g) from each individual were digested with HinfI, AluI and HaeIII under conditions recommended by the manufacturers (Boehringer Mannheim), in the presence of spermidine trichloride and recovered by ethanol precipitation. The resultant DNA fragments of the constitutional and tumour DNA of each patient were electrophoresed in adjacent tracks through a 22cm long 1.0% agarose gel at 35 V for 36 h at room temperature until all DNA fragments <2kb long had electrophoresed off the gel. The separated DNA fragments were transferred to a Schleicher and Schull nitrocellulose membrane (BA 85) and hybridised to 32P-labelled minisatellite probe 33.15 or 33.6 as described elsewhere (Jeffreys et al., 1985a, b) . After hybridisation, filters were washed for 1 h in 1 x SSC at 65'C and autoradiographed without intensifying screens for 3-4 days at -70°C.
Results
The tumour and constitutional DNA fingerprints were indistinguishable in the majority (25/35) of cancer patients studied ( Figure 1 , Table I ). In nine cases, including some myelomas, breast carcinomas and gastro-intestinal tract carcinomas, there were shifts in the relative intensities of hypervariable DNA fragments in the tumour DNA when compared to the constitutional DNA. In two cases (patients AC and FB), the shifts in band intensities were also seen in DNA fingerprints produced after digestion with AluI or HaeIII confirming that these changes were not due to tumour-specific DNA methylation changes which could Br. J. Cancer (1987) , 55, [353] [354] [355] [356] C) The Macmillan Press Ltd., 1987 DNAs of patients PW, FB and AC with minisatellite probe 33.6, which detects hypervariable DNA fragments derived from a different set of loci , did not show any differences between tumour and constitutional DNA fingerprints (data not shown).
Discussion
Cancer is a multistep process that probably results from an accumulation of a series of somatic changes. DNA fingerprint analysis provides a useful new approach for studying some of these somatic changes in tumour DNA. A number of processes could result in the alteration of DNA fingerprints. For example, loss of chromosomes or chromosomal regions through deletion, mitotic nondisjunction or mitotic recombination would lead to loss of associated minisatellite fragments. Conversely, localised amplification of DNA (Stark & Wahl, 1984; Schimke, 1984) including a minisatellite would cause specific band intensification. Tissue-or tumour-specific changes in DNA methylation (Goelz et al., 1985) could also affect DNA fingerprints; the latter can be excluded by using restriction enzymes such as AluI The patients' initials are shown above the blots and correspond to details given in Table I (Jeffreys et al., 1985b) . Thirty-five different tumours of which eight were of gastro-intestinal origin have been studied. Mutant bands in tumour DNA fingerprints were observed in three cases, all of gastro-intestinal origin (two rectal and one gastrooesophageal carcinoma). In two cases where adjacent normal tissue was available for study, no changes were seen on comparing normal tissue and blood DNA fingerprints. This suggests that the somatic mutations seen are tumour specific rather than tissue specific. However, it is not clear whether these novel bands are related to the pathogenesis of the tumour, or whether they are the products of unequal mitotic recombination events which arise in all tissues but only become apparent on clonal expansion of a malignant cell. In any event, such changes even though not directly related to the tumour phenotype could provide novel markers for studying tumour clonality and tumour progression. Also, it is presently not possible to determine whether the somatic mutations observed in the three gastro-intestinal tumours involve the same locus. It should be possible to clone the clearly-resolved mutant minisatellite from patient PW to provide a locus-specific probe (Wong et al., 1986 ) suitable for studying the tumours from patients FB and AC which should help to resolve the issue of whether the genomic rearrangements in the tumours of patients PW, FB and AC involve a common chromosomal region.
Recently, an oncogene (onc-D or trk) has been isolated from the DNA of a human carcinoma of the colon and was shown to have arisen by recombination between two separate loci (Martin-Zanca et al., 1986) . It is possible that an enhanced level of recombination occurs in many tumours, rearranging both oncogenes and minisatellites. Some of these rearrangements are detectable by karyotype analysis e.g. generation of the Philadelphia chromosome in chronic myeloid leukaemia (Heisterkamp et al., 1983) and translocation of the c-myc oncogene in Burkitt's lymphoma (Yunis, 1983) . In view of the evidence that the majority of the cancers show substantial genetic rearrangement it might have been expected that a higher proportion of the tumours analysed would have shown differences in the DNA fingerprints as compared to the constitutional DNA. One explanation for this unexpected finding is that the DNA fingerprints obtained from the minisatellite probe 33.15 are derived from an estimated number of 30 loci and therefore will not detect aneuploidy or hemizygosity over a large proportion of the human genome. Nevertheless, DNA fingerprinting analysis offers another approach to the detection of previously uncharacterised genomic rearrangements. Locus-specific hybridisation probes could be prepared from a mutant minisatellite and then used both to determine the frequency of genomic rearrangements at this locus in other cancers and to localise the minisatellite within the human genome. This approach is currently being tested by cloning the mutant minisatellite from patient PW.
